The quinacrine experience in a population of patients with cutaneous lupus erythematosus and dermatomyositis-Reference-Cited by-同舟云学术

The quinacrine experience in a population of patients with cutaneous lupus erythematosus and dermatomyositis

Published:2017-08 Issue:2 Volume:77 Page:374-377
ISSN:0190-9622
Container-title:Journal of the American Academy of Dermatology
language:en
Short-container-title:Journal of the American Academy of Dermatology

Author:

Mittal Lavanya,Werth Victoria P.

Publisher

Elsevier BV

Subject

Dermatology

Reference5 articles.

1. FDA Briefing Document. Paper presented at Pharmacy Compounding Advisory Committee (PCAC) Meeting; March 8-9, 2016. Available at: http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/PharmacyCompoundingAdvisoryCommittee/UCM486146.pdf. Accessed August 1, 2016.

2. Impact of smoking in cutaneous lupus erythematosus;Piette;Arch Dermatol,2012

3. Response to antimalarial agents in cutaneous lupus erythematosus: a prospective analysis;Chang;Arch Dermatol,2011

4. Aplastic anemia induced by quinacrine;Biro;Arch Dermatol,1965

5. Aplastic anemia in soldiers treated with atabrine (quinacrine);Custer;Am J Med Sci,1946

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasmacytoid dendritic cells are not major producers of type 1 interferon in cutaneous lupus: An in depth immunoprofile of subacute and discoid lupus;Journal of Investigative Dermatology;2023-12

2. Cutaneous Lupus Erythematosus: Review and Considerations for Older Populations;Drugs & Aging;2023-11-22

3. Chronic Erythematous Plaques Around the Ears;Cutis;2023-02-01

4. Response of dermatomyositis to the antimalarial quinacrine: A retrospective cohort study;Journal of the American Academy of Dermatology;2021-04

5. Editorial: Quinacrine: au Revoir or Adieu? This safe and effective drug should be reintroduced;Current Opinion in Rheumatology;2021-03-17